Hie‐Won Hann

3.0k total citations
70 papers, 2.1k citations indexed

About

Hie‐Won Hann is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Hie‐Won Hann has authored 70 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Epidemiology, 37 papers in Hepatology and 13 papers in Molecular Biology. Recurrent topics in Hie‐Won Hann's work include Hepatitis B Virus Studies (37 papers), Hepatitis C virus research (28 papers) and Liver Disease Diagnosis and Treatment (25 papers). Hie‐Won Hann is often cited by papers focused on Hepatitis B Virus Studies (37 papers), Hepatitis C virus research (28 papers) and Liver Disease Diagnosis and Treatment (25 papers). Hie‐Won Hann collaborates with scholars based in United States, China and South Korea. Hie‐Won Hann's co-authors include Audrey E. Evans, Mark W. Stahlhut, Giulio J. D’Angio, Kathleen J. Propert, James A. Anderson, Baruch S. Blumberg, Eng Kiong Teo, Thierry Poynard, Fabian Wong and Steven‐Huy B. Han and has published in prestigious journals such as Science, New England Journal of Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Hie‐Won Hann

66 papers receiving 2.1k citations

Peers

Countries citing papers authored by Hie‐Won Hann

Since Specialization

Citations

This map shows the geographic impact of Hie‐Won Hann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hie‐Won Hann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hie‐Won Hann more than expected).

Fields of papers citing papers by Hie‐Won Hann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hie‐Won Hann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hie‐Won Hann. The network helps show where Hie‐Won Hann may publish in the future.

Co-authorship network of co-authors of Hie‐Won Hann

This figure shows the co-authorship network connecting the top 25 collaborators of Hie‐Won Hann. A scholar is included among the top collaborators of Hie‐Won Hann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hie‐Won Hann. Hie‐Won Hann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HBV Transmission Knowledge Among Korean-American Chronic Hepatitis B Patients in the United States 2024 ·Journal of Community Health ·Giyoung Lee, Hee‐Soon Juon, (unknown), Katherine Clegg Smith, Hie‐Won Hann, (unknown), Ann C. Klassen	1
2	Review of Related Factors for Persistent Risk of Hepatitis B Virus-Associated Hepatocellular Carcinoma 2024 ·Cancers ·Nevin Varghese, (unknown), (unknown), (unknown), Dina Halegoua‐De Marzio, Hie‐Won Hann	9
3	Chronic Hepatitis B: A Summarized Anecdote of Complexities in Natural History, Treatment, and Complications 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Dina Halegoua‐De Marzio, Hie‐Won Hann	0
4	Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks 2023 ·Alimentary Pharmacology & Therapeutics ·Scott Fung, Calvin Q. Pan, Grace Lai–Hung Wong, Wai‐Kay Seto, Sang Hoon Ahn, Chi‐Yi Chen, Hie‐Won Hann, Maciej Jabłkowski, Yoon Jun Kim, Cihan Yurdaydın, Cheng‐Yuan Peng, Tuan Nguyen, Hiroshi Yatsuhashi, John F. Flaherty, Leland J. Yee, (unknown), Hongyuan Wang, (unknown), Young‐Suk Lim, Marı́a Buti	7
5	Poor Prognosis in HBV-associated Hepatocellular Carcinoma After Successful Viral Suppression: A Case Series Highlighting a Need for a Cure 2023 ·(unknown), Daniel Garrido, Dina Halegoua‐DeMarzio, Christopher Roth, Hie‐Won Hann	4
6	The Role of Host in the Spectrum of Outcomes in Family Clusters of Hepatitis Infection: From Asymptomatic to Hepatocellular Carcinoma 2023 ·Case Reports in Gastroenterology ·(unknown), Anh Tuấn Nguyễn, Divya Chalikonda, Dina Halegoua‐DeMarzio, Hie‐Won Hann	2
7	The Long Game: A Functional Cure Is Possible with Nucleoside Analogues and the Tincture of Time 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Dina Halegoua‐De Marzio, Hie‐Won Hann	1
8	Novel urine cell-free DNA methylation markers for hepatocellular carcinoma 2023 ·Scientific Reports ·Selena Y. Lin, Wei Xia, Amy K. Kim, (unknown), (unknown), (unknown), Zhili Wang, James P. Hamilton, (unknown), Hie‐Won Hann, Ting‐Tsung Chang, Chi‐Tan Hu, (unknown), T. Gade, Ying‐Hsiu Su	6
9	Persistently Elevated HBV Viral-Host Junction DNA in Urine as a Biomarker for Hepatocellular Carcinoma Minimum Residual Disease and Recurrence: A Pilot Study 2023 ·Diagnostics ·Selena Y. Lin, Dina Halegoua‐De Marzio, Peter D. Block, (unknown), Jesse Civan, (unknown), Wei Song, Hie‐Won Hann, Ying‐Hsiu Su	2
10	Chronicles of HBV and the Road to HBV Cure 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Hie‐Won Hann	2
11	Hepatitis B Virus (HBV) Reactivation Following Immunosuppression in HBsAg(+) Carriers 2016 ·North American Journal of Medicine and Science ·(unknown), Hie‐Won Hann	0
12	Cell-free circulating mitochondrial DNA content and risk of hepatocellular carcinoma in patients with chronic HBV infection 2016 ·Scientific Reports ·Ling Li, Hie‐Won Hann, Shaogui Wan, Richard S. Hann, Chun Wang, Yinzhi Lai, (unknown), Alison A. Evans, Ronald E. Myers, Zhong Ye, Bingshan Li, Jinliang Xing, Hushan Yang	72
13	Circulating Mitochondrial DNA Content Associated with the Risk of Liver Cirrhosis: A Nested Case–Control Study 2015 ·Digestive Diseases and Sciences ·Chun Wang, Hie‐Won Hann, Richard S. Hann, Shaogui Wan, Ronald E. Myers, Zhong Ye, Jinliang Xing, Hushan Yang	13
14	A review of the one-year incidence of resistance to lamivudine in the treatment of chronic hepatitis B 2008 ·Hepatology International ·Hie‐Won Hann, (unknown), Jonathan S. Dixon, Keith Barker	8
15	A 1-Year Trial of Telbivudine, Lamivudine, and the Combination in Patients With Hepatitis B e Antigen—Positive Chronic Hepatitis B 2005 ·Gastroenterology ·Ching‐Lung Lai, Nancy Leung, Eng Kiong Teo, Myron J. Tong, Fabian Wong, Hie‐Won Hann, Steven‐Huy B. Han, Thierry Poynard, Maureen Myers, George Chao	304
16	A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus-related cirrhosis 2003 ·Liver Transplantation ·Hie‐Won Hann, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	44
17	Hepatocellular Carcinoma After Systemic Chemotherapy: Gadolinium-Enhanced MR Measurement of Necrosis by Volume Histogram 2001 ·Journal of Computer Assisted Tomography ·Yong Yeon Jeong, Donald G. Mitchell, Hie‐Won Hann, (unknown), Heoung Keun Kang, George Holland, Robert L. Capizzi	4
18	Screening for Neuroblastoma in North America 1992 ·The Pediatric Infectious Disease Journal ·William G. Woods, Mendel Tuchman, Mark L. Bernstein, Jean‐Marie Leclerc, L Brisson, Thomas Look, Garrett M. Brodeur, Hiroyuki Shimada, Hie‐Won Hann, Leslie L. Robison, Jonathan J. Shuster, Bernard Lemieux	4
19	Antitumor effect of deferoxamine on human hepatocellular carcinoma growing in athymic nude mice 1992 ·Cancer ·Hie‐Won Hann, Mark W. Stahlhut, Raphael Rubin, Willis C. Maddrey	85
20	Iron enhances tumor growth. Observation on spontaneous mammary tumors in mice 1991 ·Cancer ·Hie‐Won Hann, Mark W. Stahlhut, Hyman Menduke	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact